|
Claudin 16
Scientific background:
Summary: Mutations of this gene cause primary hypomagnesaemia.
Gene: The gene has a size of 23 kb. It is also known as paracellin-1 (PCLN1). Recent evidence has shown that this gene belongs to a family called claudines. It consists of 5 exons and it is located on chromosome 3 (3q27).
Pathology: The translation product is a 305 amino acid proteine that consists of 4 transmembrane domains and intracellular amino- and C-termini. The protein is exclusively found in the kidney. Along the nephron it is located in the thick ascending limb of Henle's loop and in the distal convolution where it forms tight junction together with occludin. Obviously it regulates net paracellular magnesium flux.
Clinical signs: The predominant clinical symptom is hypomagnesemia accompanied by hypercalciuria. This condition predisposes to the development of kidney stones in heterozygous patients. In contrary, in homozygous patients there is nephrocalcinosis and renal failure in childhood.
Epidemiology: Only few families have been described.
Interpretation: The therapeutic consequences include family counseling and prophylaxis for kidney stone formation.
Test strategy: Predominant indications for molecular diagnostic are family counseling and improvement of diagnostic precision.
Methodology:
|
clinical test |
Method |
Genomic sequencing of the entire coding region |
| Turn-around time |
10 working days |
| Effort |
little |
| Specimen |
DNA |
| Quality assessment |
Internal quality control only |
| |
All known and new missense, nonsense and splice mutations can be detected. |
 |
|
clinical test |
Method |
Carrier testing |
| Turn-around time |
5 working days |
| Effort |
little |
| Specimen |
DNA |
| Quality assessment |
Internal quality control only |
| |
The test is only specific about the mutation already known in this kindred. |
|